Robert Neil Goldstone, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rectal Neoplasms | 12 | 2023 | 1195 | 1.240 |
Why?
|
Anus Neoplasms | 3 | 2017 | 332 | 1.210 |
Why?
|
Colectomy | 6 | 2022 | 681 | 1.190 |
Why?
|
Tunica Intima | 2 | 2018 | 464 | 1.000 |
Why?
|
Colorectal Neoplasms | 9 | 2023 | 6754 | 0.840 |
Why?
|
Colitis, Ulcerative | 4 | 2023 | 1901 | 0.800 |
Why?
|
Intestinal Perforation | 2 | 2021 | 252 | 0.770 |
Why?
|
Diverticulitis, Colonic | 2 | 2021 | 127 | 0.770 |
Why?
|
Colonic Neoplasms | 8 | 2022 | 2542 | 0.760 |
Why?
|
Photochemotherapy | 2 | 2018 | 804 | 0.760 |
Why?
|
Laparoscopy | 6 | 2022 | 2121 | 0.700 |
Why?
|
Appendiceal Neoplasms | 1 | 2021 | 145 | 0.680 |
Why?
|
HIV Seropositivity | 2 | 2017 | 970 | 0.680 |
Why?
|
Carcinoma in Situ | 2 | 2016 | 802 | 0.640 |
Why?
|
Precancerous Conditions | 4 | 2017 | 971 | 0.590 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2023 | 2410 | 0.570 |
Why?
|
Colorectal Surgery | 1 | 2019 | 129 | 0.570 |
Why?
|
Anal Canal | 2 | 2017 | 376 | 0.570 |
Why?
|
Photosensitizing Agents | 2 | 2018 | 602 | 0.560 |
Why?
|
Hyperplasia | 3 | 2018 | 1183 | 0.540 |
Why?
|
Intestinal Obstruction | 1 | 2019 | 424 | 0.530 |
Why?
|
Colitis | 1 | 2023 | 1149 | 0.510 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2018 | 277 | 0.490 |
Why?
|
Arteriovenous Fistula | 1 | 2018 | 315 | 0.490 |
Why?
|
Neoadjuvant Therapy | 7 | 2023 | 2721 | 0.460 |
Why?
|
Catheter Ablation | 2 | 2017 | 2746 | 0.460 |
Why?
|
Income | 1 | 2021 | 1904 | 0.420 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2019 | 1130 | 0.410 |
Why?
|
Light Coagulation | 1 | 2011 | 72 | 0.410 |
Why?
|
Abdominal Abscess | 2 | 2022 | 154 | 0.380 |
Why?
|
Corneal Wavefront Aberration | 1 | 2010 | 6 | 0.380 |
Why?
|
HIV Seronegativity | 1 | 2011 | 211 | 0.370 |
Why?
|
Homosexuality, Male | 3 | 2017 | 1238 | 0.370 |
Why?
|
Infrared Rays | 1 | 2011 | 249 | 0.370 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2023 | 9185 | 0.360 |
Why?
|
Health Expenditures | 2 | 2022 | 2346 | 0.360 |
Why?
|
Lasers, Excimer | 1 | 2010 | 72 | 0.350 |
Why?
|
Stromal Cells | 1 | 2015 | 1353 | 0.350 |
Why?
|
Keratomileusis, Laser In Situ | 1 | 2010 | 88 | 0.340 |
Why?
|
Adenocarcinoma | 6 | 2022 | 6347 | 0.330 |
Why?
|
Contact Lenses | 1 | 2010 | 145 | 0.330 |
Why?
|
Anastomosis, Surgical | 3 | 2021 | 985 | 0.300 |
Why?
|
Myopia | 1 | 2010 | 254 | 0.300 |
Why?
|
General Surgery | 1 | 2019 | 1633 | 0.300 |
Why?
|
Colonic Polyps | 1 | 2011 | 542 | 0.280 |
Why?
|
Colon | 3 | 2020 | 1773 | 0.270 |
Why?
|
Colonoscopy | 3 | 2022 | 1365 | 0.270 |
Why?
|
Appendicitis | 2 | 2022 | 644 | 0.270 |
Why?
|
Retrospective Studies | 26 | 2023 | 77098 | 0.260 |
Why?
|
Medicare | 1 | 2022 | 6532 | 0.240 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4029 | 0.230 |
Why?
|
Matched-Pair Analysis | 1 | 2023 | 288 | 0.220 |
Why?
|
Emergencies | 2 | 2019 | 1164 | 0.210 |
Why?
|
Hypoalbuminemia | 1 | 2023 | 87 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 5 | 2020 | 6534 | 0.200 |
Why?
|
Colon, Transverse | 1 | 2021 | 23 | 0.200 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2021 | 83 | 0.190 |
Why?
|
Hospitals, Community | 1 | 2023 | 348 | 0.190 |
Why?
|
Neoplasm Staging | 10 | 2023 | 11001 | 0.180 |
Why?
|
Hospices | 1 | 2023 | 264 | 0.180 |
Why?
|
Anastomotic Leak | 1 | 2021 | 162 | 0.180 |
Why?
|
New York | 2 | 2020 | 886 | 0.180 |
Why?
|
Abdomen, Acute | 1 | 2019 | 123 | 0.170 |
Why?
|
Rectum | 2 | 2023 | 903 | 0.170 |
Why?
|
Cultural Competency | 1 | 2022 | 288 | 0.170 |
Why?
|
Humans | 46 | 2023 | 742088 | 0.160 |
Why?
|
Diverticulitis | 1 | 2021 | 169 | 0.160 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2021 | 3471 | 0.160 |
Why?
|
Treatment Outcome | 10 | 2023 | 62966 | 0.160 |
Why?
|
Proctoscopy | 1 | 2017 | 42 | 0.160 |
Why?
|
Treatment Refusal | 1 | 2020 | 416 | 0.150 |
Why?
|
Disease-Free Survival | 5 | 2022 | 6891 | 0.140 |
Why?
|
Aged | 14 | 2023 | 162944 | 0.140 |
Why?
|
Metformin | 1 | 2023 | 829 | 0.140 |
Why?
|
Hospice Care | 1 | 2023 | 671 | 0.140 |
Why?
|
Prognosis | 8 | 2022 | 29010 | 0.130 |
Why?
|
Rose Bengal | 1 | 2016 | 115 | 0.130 |
Why?
|
Middle Aged | 17 | 2023 | 213127 | 0.130 |
Why?
|
Neoplasms, Second Primary | 1 | 2023 | 1052 | 0.130 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2016 | 283 | 0.130 |
Why?
|
Postoperative Complications | 6 | 2023 | 15244 | 0.130 |
Why?
|
Digestive System Surgical Procedures | 1 | 2020 | 576 | 0.130 |
Why?
|
Sus scrofa | 1 | 2016 | 437 | 0.130 |
Why?
|
Emigrants and Immigrants | 1 | 2021 | 519 | 0.120 |
Why?
|
Disease Progression | 1 | 2011 | 13256 | 0.120 |
Why?
|
Vascular Grafting | 1 | 2016 | 142 | 0.120 |
Why?
|
Male | 21 | 2023 | 349538 | 0.120 |
Why?
|
Elasticity | 1 | 2016 | 657 | 0.120 |
Why?
|
Anemia | 1 | 2023 | 1499 | 0.110 |
Why?
|
Robotics | 1 | 2021 | 892 | 0.110 |
Why?
|
Saphenous Vein | 1 | 2016 | 531 | 0.110 |
Why?
|
Intestines | 1 | 2022 | 1923 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1970 | 0.100 |
Why?
|
Papillomavirus Infections | 2 | 2017 | 1585 | 0.100 |
Why?
|
Carotid Arteries | 1 | 2016 | 952 | 0.100 |
Why?
|
Terminal Care | 1 | 2023 | 1688 | 0.100 |
Why?
|
Demography | 1 | 2016 | 1650 | 0.100 |
Why?
|
Adult | 13 | 2022 | 213712 | 0.100 |
Why?
|
Swine | 2 | 2022 | 5934 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12242 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3164 | 0.090 |
Why?
|
Proportional Hazards Models | 3 | 2022 | 12344 | 0.090 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39004 | 0.090 |
Why?
|
Female | 17 | 2023 | 379592 | 0.090 |
Why?
|
Appendectomy | 2 | 2022 | 400 | 0.090 |
Why?
|
Refraction, Ocular | 1 | 2010 | 181 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2021 | 1794 | 0.080 |
Why?
|
Bariatric Surgery | 1 | 2018 | 940 | 0.080 |
Why?
|
Neoplasm Invasiveness | 3 | 2022 | 3612 | 0.080 |
Why?
|
Age Factors | 2 | 2022 | 18355 | 0.080 |
Why?
|
Developing Countries | 1 | 2021 | 2789 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7141 | 0.080 |
Why?
|
Patient Care Team | 1 | 2019 | 2527 | 0.080 |
Why?
|
Obesity, Morbid | 1 | 2018 | 1204 | 0.080 |
Why?
|
Abscess | 2 | 2022 | 607 | 0.080 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3070 | 0.080 |
Why?
|
Immunohistochemistry | 2 | 2022 | 11363 | 0.070 |
Why?
|
Young Adult | 5 | 2021 | 56350 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8300 | 0.070 |
Why?
|
Crohn Disease | 1 | 2019 | 2301 | 0.070 |
Why?
|
Pain, Postoperative | 1 | 2016 | 1638 | 0.070 |
Why?
|
Risk Factors | 4 | 2023 | 72145 | 0.070 |
Why?
|
Graft Survival | 1 | 2016 | 3733 | 0.070 |
Why?
|
Mass Screening | 1 | 2021 | 5238 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2022 | 7276 | 0.060 |
Why?
|
Alphapapillomavirus | 1 | 2008 | 221 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3510 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2019 | 5310 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3151 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2015 | 1625 | 0.060 |
Why?
|
Pilot Projects | 1 | 2017 | 8297 | 0.060 |
Why?
|
United States | 6 | 2023 | 69693 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10163 | 0.060 |
Why?
|
Length of Stay | 3 | 2022 | 6294 | 0.060 |
Why?
|
Logistic Models | 1 | 2019 | 13403 | 0.060 |
Why?
|
Abdomen | 1 | 2009 | 1107 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2015 | 3278 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2021 | 57683 | 0.050 |
Why?
|
Stem Cells | 1 | 2015 | 3563 | 0.050 |
Why?
|
Survival Rate | 3 | 2020 | 12773 | 0.050 |
Why?
|
Internship and Residency | 1 | 2022 | 5774 | 0.050 |
Why?
|
Adolescent | 5 | 2021 | 85649 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2712 | 0.050 |
Why?
|
Rats | 1 | 2018 | 24265 | 0.050 |
Why?
|
Visual Acuity | 1 | 2010 | 2520 | 0.050 |
Why?
|
Prospective Studies | 3 | 2022 | 53187 | 0.050 |
Why?
|
Inpatients | 2 | 2023 | 2495 | 0.050 |
Why?
|
Colon, Sigmoid | 1 | 2020 | 118 | 0.040 |
Why?
|
Time Factors | 2 | 2011 | 40054 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 2009 | 1864 | 0.040 |
Why?
|
RNA, Viral | 1 | 2008 | 2899 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2015 | 19223 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18006 | 0.040 |
Why?
|
Emigration and Immigration | 1 | 2021 | 403 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 23320 | 0.040 |
Why?
|
Developed Countries | 1 | 2021 | 436 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2015 | 11470 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13019 | 0.040 |
Why?
|
Animals | 3 | 2022 | 168561 | 0.040 |
Why?
|
Nursing Homes | 1 | 2023 | 1034 | 0.030 |
Why?
|
SEER Program | 1 | 2021 | 1507 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2021 | 1606 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 7716 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1613 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1317 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 20774 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2906 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 21596 | 0.030 |
Why?
|
Endoscopy | 1 | 2022 | 1774 | 0.030 |
Why?
|
Cost of Illness | 1 | 2021 | 1852 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3564 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3571 | 0.020 |
Why?
|
Overweight | 1 | 2021 | 2366 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 40450 | 0.020 |
Why?
|
Curriculum | 1 | 2022 | 3589 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8621 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6191 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10372 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2019 | 3465 | 0.020 |
Why?
|
Genotype | 1 | 2022 | 12946 | 0.020 |
Why?
|
Serum Albumin | 1 | 2009 | 674 | 0.020 |
Why?
|
Clinical Competence | 1 | 2022 | 4681 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 20928 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 21719 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5304 | 0.010 |
Why?
|
Diet | 1 | 2021 | 7923 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6171 | 0.010 |
Why?
|
Biopsy | 1 | 2008 | 6756 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14720 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12958 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 15056 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15530 | 0.010 |
Why?
|
Prevalence | 1 | 2008 | 15194 | 0.010 |
Why?
|
Child | 1 | 2018 | 77478 | 0.010 |
Why?
|